Company Profiles

driven by the PitchBook Platform

Regenesis Biomedical

Description

Developer of noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery.

1997

Founded

PRIVATE

Status

51-200

Employees

Series C

Latest Deal Type

$5.2M

Latest Deal Amount

$15.7M

Total Amount Raised

Description

Developer of noninvasive regenerative medicine products. The company offers Provant Therapy System, a medical device that aids in reduction of pain and swelling of skin and soft tissues following surgery.

Website:

www.regenesisbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Primary Office

5301 North Pima Road Scottsdale, AZ 85250United States +1 (877) 970-4970
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Regenesis Biomedical's full profile, request a free trial.

Regenesis Biomedical Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Regenesis Biomedical Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Regenesis Biomedical Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aztec Venture NetworkVenture CapitalMinority000 0000000 0000
Desert AngelsAngel GroupMinority000 0000000 0000
Fulcrum Equity PartnersGrowth/ExpansionMinority000 0000000 0000
Solstice CapitalVenture CapitalMinority000 0000000 0000
TGap VenturesVenture CapitalMinority000 0000000 0000
Aztec Venture Network Venture Capital
Desert Angels Angel Group
Fulcrum Equity Partners Growth/Expansion
Solstice Capital Venture Capital
TGap Ventures Venture Capital

Regenesis Biomedical Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Scott BrooksChief Executive Officer & Board Member
Dennis GengeChief Financial Officer & Vice President
Chris D'ErricoDirector of Sales, East
Art LoyaDirector, Engineering
Mark DavisVice President of Clinical Research and Regulatory Affairs
Scott Brooks Chief Executive Officer & Board Member
Dennis Genge Chief Financial Officer & Vice President
Chris D'Errico Director of Sales, East
Art Loya Director, Engineering
Mark Davis Vice President of Clinical Research and Regulatory Affairs

Regenesis Biomedical Board Members (7)

NameRepresentingRoleSinceContact
Info
Henry NewmanSolstice CapitalBoard Member000 0000
Jack Ahrens IITGap VenturesBoard Member000 0000
John XenosRegenesis BiomedicalBoard Member000 0000
R. NelsonSelfBoard Member000 0000
Richard ShirkSelfBoard Member000 0000
Henry Newman Board Member Solstice Capital
Jack Ahrens II Board Member TGap Ventures
John Xenos Board Member Regenesis Biomedical
R. Nelson Board Member Self
Richard Shirk Board Member Self
Request full access to PitchBook